Efficacy and safety of empagliflozin in GSD type Ib: data from an international questionnaire survey | Webinar Recording

10th May 2022

Want to access this resource?

REGISTER NOW

OR LOGIN IF YOU ARE ALREADY REGISTERED

DESCRIPTION

A paediatric metabolic specialist presents international data on the growing use of empagliflozin to manage neutrophilia in GSD type Ib.

Author